semaglutide depression anxiety from The interplay of gut microbiota, obesity, and depression: insights and interventions Association between GLP-1 receptor agonist

First, the published preclinical literature for the constituent compounds BPC-157, TB-500, and GHK-Cu covers skin biology, ECM remodeling, hair follicle research, and wound repair across decades of work

Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation

Its earnings performance surpassed Wall Street's expectations, according to Zacks Investment Research

The length of treatment can vary depending on individual health goals and medical guidance